Beijing Biote Pharmaceutical Co.,Ltd
Beijing Biote Pharmaceutical Co.,Ltd
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct Carcinoma | Salivary Gland Neoplasm Duct | Recruiting | Phase 2 | 2025-09-23 | NCT06348264 |